Screener
ARS Pharmaceuticals, Inc. SPRY Balance Sheet Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| $8.16M-84.2% | $24.32M-39.0% | $41.32M-18.7% | $59.56M+50.2% | $51.54M+40.7% | ||
| $135.68M-28.1% | $176.65M-25.1% | $203.67M-22.6% | $228.65M+38.6% | $188.59M+3.6% | ||
| $46.84M+86.4% | $28.66M+208% | $25.35M+210% | $36.45M+4,616% | $25.13M— | ||
| $19.05M+42.4% | $23.22M+94.5% | $23.05M+334% | $13.65M+1,808% | $13.37M— | ||
| $211.51M-24.8% | $245.24M-19.3% | $284.9M-14.8% | $338.86M+62.3% | $281.44M+27.5% | ||
| $2.09M+94.0% | $2.29M+113% | $2.47M+131% | $1.21M+43.4% | $1.08M+69.0% | ||
| $13.9M+7.2% | $14.18M+95.8% | $14.45M+96.1% | $14.73M+96.4% | $12.97M— | ||
| $249.5M-20.4% | $287.57M-12.1% | $327.65M-6.7% | $372.8M+71.3% | $313.47M+41.2% | ||
| $59.73M+34.9% | $48.26M+78.7% | $37.95M+66.1% | $49.77M+201% | $44.26M+574% | ||
| $535K-28.3% | $757K+40.2% | $609K+9.3% | $526K— | $746K— | ||
| $60.86M+33.5% | $49.61M+79.6% | $39.15M+67.0% | $50.88M+206% | $45.6M+578% | ||
| $96.68M— | $96.52M— | $96.37M— | $96.23M— | —— | ||
| $236.98M+95.6% | $226.26M+130% | $213.39M+126% | $225.15M+1,254% | $121.15M+1,702% | ||
| $10K0.0% | $10K0.0% | $10K0.0% | $10K0.0% | $10K0.0% | ||
| -$417.56M-107% | -$355.22M-126% | -$294.6M-139% | -$253.28M-46.2% | -$202.13M-31.2% | ||
| $12.51M-93.5% | $61.31M-73.2% | $114.26M-55.5% | $147.66M-26.5% | $192.32M-10.6% | ||
| $249.5M-20.4% | $287.57M-12.1% | $327.65M-6.7% | $372.8M+71.3% | $313.47M+41.2% |
FAQ
- What are ARS Pharmaceuticals, Inc.'s total assets?
- ARS Pharmaceuticals, Inc. (SPRY) holds $249.5M in total assets, down 20.4% year over year.
- How much debt does ARS Pharmaceuticals, Inc. have?
- ARS Pharmaceuticals, Inc. carries $96.7M in total debt against $12.5M of shareholders' equity, a debt-to-equity ratio of 7.73.
- How much cash does ARS Pharmaceuticals, Inc. have?
- ARS Pharmaceuticals, Inc. holds $8.2M in cash and equivalents.
- Can ARS Pharmaceuticals, Inc. cover its short-term obligations?
- Its current ratio is 3.48 — current assets exceed current liabilities.
- Where does ARS Pharmaceuticals, Inc.'s balance sheet data come from?
- Every line is extracted from ARS Pharmaceuticals, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
